Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

This study has been terminated.

Study NCT00050687 Information provided by Titan Pharmaceuticals

First Received: December 17, 2002 Last Updated: August 19, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	February 2005
Estimated Primary Completion Date:	No date given